Research Support (Psychedelic and Psychoactive Substances)

Research Support (Psychedelic and Psychoactive Substances) is sponsored by UW–Madison Center for Psychedelic Research and Education. This opportunity supports mission-aligned projects and measurable outcomes.

Center for Psychedelic Research and Education – UW–Madison U niversity of W isconsin –Madison Message from the Director The Center is “Transdisciplinary” in that we are seeking to develop collaborations and provide resources across the UW Madison’s multiple schools, centers, and institutes. These include the Schools of Pharmacy, Medicine and Public Health, Nursing, Engineering, Social Work, and Latin, Caribbean, and Iberian Studies.

Note under the “Education” tab on the Center’s landing page that the School of Pharmacy has developed an online Master of Science program in Psychoactive (there it is again) Pharmaceutical Investigation. Further, the Center is planning educational programming for clinicians as well as the lay public in anticipation of FDA approval of psilocybin, MDMA, and other compounds in the near future.

Thanks for visiting, and check back again soon.

UW–Madison Center for Psychedelic Research and Education Watch Dr. Cody Wenthur’s presentation “Psychedelics and Mental Health” for PBS Wisconsin Stay up-to-date with our latest news, events, and research On the forefront of research and education in psychedelic drugs and related compounds The mission of the UW–Madison Center for Psychedelic Research and Education is to support research and educational activities regarding psychedelic drugs and related compounds.

The Center supports the UW–Madison campus and the Wisconsin community with research infrastructure, such as drug dosing rooms, treatment facilitator training, and education. Although some work focuses on drugs with a clear psychedelic effect, related substances may have clinical effects on mood or behavior without the psychedelic experience, thus the use of the term “psychoactive.

” The Center supports the Master of Science in Psychoactive Pharmaceutical Investigation . The Center also seeks to establish relationships with commercial entities that would benefit from various screening tests or early stage clinical trials. The University of Wisconsin–Madison Center for Psychedelic Research and Education recognizes that research on psychedelics to date has disproportionately included white adults.

We actively seek to improve the accessibility of the research on psychedelics and psychoactive agents for persons in marginalized groups, those with lower socioeconomic backgrounds, and with barriers that include transportation, inflexible job schedules, and child care.

This outreach is intended to include both urban and rural communities, and will require attentive understanding of the concerns of the respective communities regarding this area of research. Equity in Psychedelic Therapies As psychoactive substances gain therapeutic evidence, School of Pharmacy Assistant Professor Cody Wenthur aims to reverse underrepresentation of minorities in clinical studies.

CPRE to Focus on Underserved Communities in Psychedelic Research Building on its ongoing psychedelic studies, UW–Madison has launched a program to explore the “science, history, and cultural impact of psychedelic agents” with a focus on expanding participation from research subjects of diverse and underrepresented backgrounds.